Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
1998 3
1999 3
2000 2
2001 2
2002 3
2003 4
2004 4
2005 7
2006 6
2007 8
2008 8
2009 10
2010 8
2011 12
2012 9
2013 2
2014 3
2015 14
2016 12
2017 13
2018 12
2019 15
2020 16
2021 29
2022 27
2023 21
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL, Church LWP, Murshedkar T, Billingsley PF, James ER, Chen MC, Abebe Y, Natasha Kc, Chakravarty S, Dolberg D, Healy SA, Diawara H, Sissoko MS, Sagara I, Cook DM, Epstein JE, Mordmüller B, Kapulu M, Kreidenweiss A, Franke-Fayard B, Agnandji ST, López Mikue MA, McCall MBB, Steinhardt L, Oneko M, Olotu A, Vaughan AM, Kublin JG, Murphy SC, Jongo S, Tanner M, Sirima SB, Laurens MB, Daubenberger C, Silva JC, Lyke KE, Janse CJ, Roestenberg M, Sauerwein RW, Abdulla S, Dicko A, Kappe SHI, Sim BKL, Duffy PE, Kremsner PG, Hoffman SL. Richie TL, et al. Among authors: dicko a. Expert Rev Vaccines. 2023 Jan-Dec;22(1):964-1007. doi: 10.1080/14760584.2023.2245890. Epub 2023 Aug 11. Expert Rev Vaccines. 2023. PMID: 37571809 Free PMC article. Review.
Resurgent and delayed malaria.
Greenwood B, Zongo I, Dicko A, Chandramohan D, Snow RW, Ockenhouse C. Greenwood B, et al. Among authors: dicko a. Malar J. 2022 Mar 9;21(1):77. doi: 10.1186/s12936-022-04098-6. Malar J. 2022. PMID: 35264158 Free PMC article. Review.
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Datoo MS, Dicko A, Tinto H, Ouédraogo JB, Hamaluba M, Olotu A, Beaumont E, Ramos Lopez F, Natama HM, Weston S, Chemba M, Compaore YD, Issiaka D, Salou D, Some AM, Omenda S, Lawrie A, Bejon P, Rao H, Chandramohan D, Roberts R, Bharati S, Stockdale L, Gairola S, Greenwood BM, Ewer KJ, Bradley J, Kulkarni PS, Shaligram U, Hill AVS; R21/Matrix-M Phase 3 Trial Group. Datoo MS, et al. Among authors: dicko a. Lancet. 2024 Feb 10;403(10426):533-544. doi: 10.1016/S0140-6736(23)02511-4. Epub 2024 Feb 1. Lancet. 2024. PMID: 38310910 Free article. Clinical Trial.
[Mouth ulcers].
Dicko A, Toulemonde A, Hoareau F, Avenel-Audran M, Verret JL. Dicko A, et al. Ann Dermatol Venereol. 2007 Apr;134(4 Pt 1):389-90. doi: 10.1016/s0151-9638(07)89200-3. Ann Dermatol Venereol. 2007. PMID: 17483765 French. No abstract available.
Malaria vaccination and rebound malaria.
Dicko A, Greenwood B. Dicko A, et al. Lancet Infect Dis. 2019 Aug;19(8):790-791. doi: 10.1016/S1473-3099(19)30282-8. Epub 2019 Jul 9. Lancet Infect Dis. 2019. PMID: 31300332 No abstract available.
Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study.
Thompson HA, Hogan AB, Walker PGT, Winskill P, Zongo I, Sagara I, Tinto H, Ouedraogo JB, Dicko A, Chandramohan D, Greenwood B, Cairns M, Ghani AC. Thompson HA, et al. Among authors: dicko a. Lancet Glob Health. 2022 Dec;10(12):e1782-e1792. doi: 10.1016/S2214-109X(22)00416-8. Lancet Glob Health. 2022. PMID: 36400084 Free article. Clinical Trial.
249 results